You may not have heard of NeuStar (NYSE: NSR ) , but the services it provides can affect you greatly. This $3 billion company is also handily beating the market as it shifts its focus to move deeper into the information and analytics industry.
NeuStar started its life as an operating unit within Lockheed Martin, and won its original contract to provide local telephone number portability services in 1996. It's kept that job and performed other services along the way, including administering the registry for the .BIZ and .US Internet domain names.
After spinning off from Lockheed and notching years of success, NeuStar began to shift its focus to information and data analytics services under CEO Lisa Hook. That led to the acquisition of TARGUSinfo in 2011.
Our roving reporter Rex Moore attended the big Cable Show in Washington, D.C., and asked NeuStar's Gary Zimmerman about the company's competitive advantages.
Five stocks enter, one stock leaves
It's incredible to think just how much of our digital and technological lives are almost entirely shaped and molded by just a handful of companies. Find out "Who Will Win the War Between the 5 Biggest Tech Stocks?" in The Motley Fool's latest free report, which details the knock-down, drag-out battle being waged by the five kings of tech. Click here to keep reading.
5 Best Insurance Stocks To Invest In 2016: ArQule Inc.(ARQL)
ArQule, Inc., a clinical-stage biotechnology company, engages in the research and development of cancer therapeutics directed toward molecular targets and biological processes. Its lead product ARQ 197 is non-adenosine triphosphate competitive inhibitor of the c-Met receptor tyrosine kinase, which is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in non-small cell lung cancer, c-Met-associated soft tissue sarcomas, pancreatic adenocarcinoma, hepatocellular carcinoma, germ cell tumors, and colorectal cancer. The company is also developing ARQ 621, a Phase I program focused on inhibition of the Eg5 kinesin spindle protein. Its clinical stage products include ARQ 501, ARQ 761, and ARQ 171, which are designed to kill cancer cells selectively while sparing normal cells through the direct activation of DNA damage response/checkpoint pathways. In addition, the company involves in pre-clinical development o f B-RAF and AKIP Kinase inhibitors. The company has collaborations with Kyowa Hakko Kirin Co., Ltd. and Daiichi Sankyo Co., Ltd. ArQule, Inc. was founded in 1993 and is headquartered in Woburn, Massachusetts.
Advisors' Opinion:- [By Roberto Pedone]
ArQule (ARQL), a clinical-stage biotechnology company, researches and develops cancer therapeutics. This stock closed up 3.4% to $1.49 in Thursday's trading session.
Thursday's Range: $1.44-$1.54
52-Week Range: $1.29-$2.94
Thursday's Volume: 908,000
Three-Month Average Volume: 567,811From a technical perspective, ARQL jumped higher here right above some near-term support at $1.40 with above-average volume. This move briefly pushed shares of ARQL back above its 50-day moving average of $1.53, before the stock closed just below that level at $1.49. This move is starting to push shares of ARQL within range of triggering a near-term breakout trade. That trade will hit if ARQL manages to take out some near-term overhead resistance levels at $1.54 to $1.60 with high volume.
Traders should now look for long-biased trades in ARQL as long as it's trending above some near-term support levels at $1.40 or at $1.35 and then once it sustains a move or close above those breakout levels with volume that hits near or above 567,811 shares. If that breakout hits soon, then ARQL will set up to re-test or possibly take out its next major overhead resistance levels at $1.66 to $1.78, or even $1.90 to $2.
10 Best Tech Stocks To Invest In Right Now: Nice Systems Ltd (NICE)
NICE-Systems Ltd. (NICE), incorporated on September 28, 1986, is a provider of solutions that enable enterprises and security organizations to extract insight from interactions, transactions and surveillance to drive business performance and ensure safety and security. Its solutions enable companies and public organizations to capture, manage, analyze and impact unstructured interaction, as well as transactional data, enabling such entities to comply with internal and governmental regulations, improve business and operational performance and address security threats while increasing situational awareness. Unstructured content includes cross-channel analysis of phone calls, chat, instant messaging and e-mail interactions to contact centers, trading floors, branches, home agents and back offices, phone calls to emergency service providers and first responders, video captured by closed circuit cameras, radio communications between emergency services��and first responders��personnel, Internet sessions, e-mail and instant messaging and security management solutions for command and control centers. In May 2010, the Company acquired Lamda Communication Networks Ltd.
On January 11, 2010, NICE completed the acquisition of certain assets and liabilities of Orsus Solutions Limited and certain subsidiaries of Orsus. On August 31, 2009, NICE and certain subsidiaries of NICE completed the acquisition of the voting securities of certain subsidiaries of Fortent, Inc. (Fortent). On August 31, 2009, NICE completed the acquisition of Hexagon System Engineering Ltd. (Hexagon). On June 17, 2009, the Company completed the acquisition of Syfact.
The Company�� products include NICE SmartCenter, NICE Perform Interaction Recording, NICE Perform eXpress (NPX), NICE Quality Management, NICE Interaction Analytics, NICE Real-Time Guidance, NICE Packaged Business Solutions, NICE Feedback, NICE IEX Workforce Management, Performance Manager, Network Embedded Logger and NiceCall Focus III. It also incl! udes Actimize Fraud Prevention Suite, Actimize Anti-Money Laundering Suite, Actimize Brokerage Compliance Suite, Actimize Enterprise Risk Case Manager, Mirra IV, NICE Inform, NiceVision Net, NiceVision ControlCenter, NiceVision Analytics, NiceVision Digital, NiceVision SafeRoute, NICE Situator, FAST alpha Silver, NiceTrack.
NICE SmartCenter leverages the synergies of the combined capabilities of NICE Perform, NICE Quality Management, NICE Interaction Analytics, NICE Feedback, IEX TotalView and Performance Manager. NICE Perform Interaction Recording records customer interactions with contact center agents, financial trading floors, investment banking and enterprises, with a separate suite of applications for contact centers and investment banking, including for organizations that have a relatively small number of input channels. NICE Perform eXpress (NPX) brings the capabilities of Nice Perform into a single box, low TCO solution based on commercial hardware for small businesses or small systems. NICE Quality Management delivers tools for implementing a multifaceted quality program encompassing agents, supervisors, evaluators and managers.
NICE Interaction Analytics utilizes a multi-dimensional analysis approach to analyze customer interactions across communication channels and provide automated business insight and root cause analysis based on speech analytics, e-mail and chat analysis, call flow analysis, screen content analysis and integration with customer relationship management (CRM) data. NICE Real-Time Guidance leverages interaction analytics in order to provide recommendations to the agent in real-time during a phone or chat interaction with a customer, popping up contextually relevant instructions to the agent within call-out windows.
NICE Packaged Business Solutions is a set of out-of-the-box solutions designed to address common contact center challenges, including Customer Churn Reduction, Sales Effectiveness, Customer Experience, Marketing Effective! ness, Col! lections Optimization, Quality Optimization, such as First Contact Resolution and Average Handling Time. NICE Feedback is a solution for collecting real-time customer feedback after a call or any other type of interaction with the organization. NICE IEX Workforce Management forecasts customer interactions, schedules agents with appropriate skills to manage and optimize level of customer service and resources, measures agent and team performance and supports managing overall contact center performance
Performance Manager maps enterprise business objectives to group and individual goals, tracks and reports performance. Network Embedded Logger offers a Linux based voice over Internet protocol (VoIP) Logger embedded in Cisco routers, suitable for branch recording with NICE Perform. NiceCall Focus III provides a voice recording system for organizations that have a relatively small number of input channels and a cost-effective solution for branch recording (TDM only) with centralized storage. Actimize Fraud Prevention Suite is a suite of focused cross-channel fraud prevention solutions, available individually or as an integrated whole, used in both real-time and batch processing to detect and prevent the fraud.
Actimize Anti-Money Laundering Suite is an end-to-end suite of solutions that are available individually or as an integrated whole used to monitor and identify suspicious activities for customers and facilitate regulatory compliance processes. Actimize Enterprise Risk Case Manager is a centralized platform for holistic case and alert management that enables an enterprise-wide approach to risk and compliance operations management. Mirra IV provides small recording system that is suited to simple recording applications, in which it can record up to 48 channels of voice traffic from a variety of analog and digital interfaces. NICE Inform provides information management solution for management of multimedia interactions for security command and control centers, enables effectiv! e managem! ent of multimedia incident information from various sources, for faster incident reconstruction, greater insight and improved response.
NiceVision Net provides a complete solution for Internet protocol (IP) video security, including encoders, decoders and network video recorders. NiceVision ControlCenter provides a control room management and network-based digital video matrix. NiceVision Analytics provides a set of video content analytics applications for automated detection of threats, safety and operational related events. NiceVision Digital provides a portfolio of digital video recorders for different capacities and performance requirements. NiceVision SafeRoute provides a solution for mobile video surveillance onboard public transport vehicles. FAST alpha Silver provides digital video monitoring and recording solution for large to mid-size applications. NiceTrack provides interception, delivery, monitoring, collection and advanced analysis of telecommunication interactions.
The Company competes with Aspect Software, Inc., Autonomy Corp., Cybertech International, eLoyalty, Genesys Telecommunicatons, Nexidia, Verint Systems Inc., ACI Worldwide, FICO, Mantas, Inc., Norkom Group plc, Oracle Corporation, SAS Institute Inc., Sungard Data Systems Inc., ASC Telecom, AudioSoft, Redbox Recorders, Bosch, Genetec Inc., IndigoVision, Milestone Systems A/S, ONSSI, Schneider Electric, Atis, ETI, JSI Telecom, Pen-link Ltd., SS8 Networks, Inc. and Trovicor.
Advisors' Opinion:- [By Monica Gerson]
NICE Systems (NASDAQ: NICE) shares fell 6.37% to $39.25 in pre-market trading after the company reported downbeat Q1 earnings and lowered its 2014 outlook.
- [By Roberto Pedone]
Nice Systems (NICE) provides software solutions that deliver insights by capturing and analyzing mass quantities of structured and unstructured data in real time from multiple sources such as interactions, transactions and surveillance. This stock closed up 2.1% to $38 in Wednesday's trading session.
Wednesday's Volume: 430,000
Three-Month Average Volume: 135,436
Volume % Change: 218%From a technical perspective, NICE trended modestly higher here back above its 50-day moving average of $37.69 with heavy upside volume. This move is quickly pushing shares of NICE within range of triggering a big breakout trade. That trade will hit if NICE manages to take out some near-term overhead resistance at $38.90 to its three-year high at $39.89 with high volume.
Traders should now look for long-biased trades in NICE as long as it's trending above its 50-day at $37.69 or above Wednesday's low of $36.91, and then once it sustains a move or close above those breakout levels with volume that hits near or above 135,436 shares. If that breakout hits soon, then NICE will set up to enter new three-year high territory, which is bullish technical price action. Some possible upside targets off that move are $43 to $45.
- [By Traders Reserve]
While J.P. Morgan (JPM) lowered their IT spending forecast for 2013, it sees a 3.6% growth on the horizon in 2014. That bodes well for NICE Systems (NICE) which provides solutions for capturing and analyzing customer interactions across communication channels such as phone, surveys, email and the Web��therwise known as a Big Data platform.
- [By Lee Jackson]
NICE Systems Ltd. (NASDAQ: NICE) is the worldwide leading provider of software solutions that enable organizations to take the next best action in order to improve customer experience and business results, ensure compliance, fight financial crime and safeguard people and assets. NICE’s solutions empower organizations to capture, analyze and apply, in real time, insights from both structured and unstructured Big Data. Investors are paid a 1.3% dividend. J.P. Morgan has a $46 price target, while the consensus sits at $44. The stock closed Tuesday at $42.20 a share.
10 Best Tech Stocks To Invest In Right Now: Jive Software Inc (JIVE)
Jive Software, Inc. (Jive), incorporated in February 2, 2001, provides a social business software platform. The Company is focused on unlocking the power of the enterprise social graph, which is the extended social network of an enterprise, encompassing relationships among its employees, customers and partners, as well as their interactions with people, content, and business information. The Company's customers use the Company's platform across broad business use cases, such as strategic alignment, that involve all employees, as well as functional use cases that improve the results of specific business activities such as sales execution or customer service. The Company sells its platform primarily through a direct sales force both domestically and internationally. As of December 31, 2012, the Company had 800 enterprise Jive Platform customers. In May 2013, Jive Software Inc acquired StreamOnce Inc.
The Company delivers a social business platform that features the innovation, creativity and ease of uses found in consumer applications combined with the security, flexibility and scalability necessary for enterprise deployment. The Company offers an enterprise-class social platform, purpose-built to enable its customers to manage workplace communication and collaboration. The Company's solution can be deployed across all employees, functional departments and business units. The Company's solution enables the Company's customers to operate both internal and external communities by offering a platform that allows communication and collaboration between and among employees, customers and partners. The Company's platform includes a recommendation engine that helps users connect to and easily locate relevant information and experts on an enterprise-wide basis across departmental and geographic boundaries, as well as across externally-facing customer and partner communities.
The Company's platform is capable of supporting deployments, including those with complex environments ! with tens of thousands of employees internally and millions of users externally. The Company provides tools to help its customers manage the critical elements of application security, including authentication, authorization and regulatory compliance. The Company enables customers to identify the impact of its platform on a particular business outcome. This includes identifying relevant user metrics, success rates and positive trends across the business. The Company's platform integrates with legacy IT infrastructure and a broad range of existing enterprise applications, including email, content management, customer relationship management, marketing automation, product development, eCommerce and instant messaging and enables access from mobile devices, browsers, desktop applications, collaboration applications and consumer social platforms.
The Company enables customers and third parties to develops applications that leverage its platform through its Jive Apps Market, built on the industry standard OpenSocial specifications. Users can easily find, purchase and install applications tailored to meet specific business needs in a variety of industries and business functions, enabling further innovation and functionality on the Company's platform. Developers can leverage the enterprise social graph to make applications more social and broaden their reach. The Company's platform has been developed to facilitate easy deployment with familiar interfaces. The Company offers its customers the ability to configure its solutions to deliver the specific functionality and user experience they want for their end-users, and the ability to modify the look and feel of its solutions to conform to their branding or other requirements. The Company's customers can use the Company's platform on demand through the public cloud, or via a private cloud. This flexible delivery model allows the Company to meet a variety of security and cost requirements and better address the needs of each customer, and enables the Co! mpany to ! target a wider range of potential customers.
The Company's flagship product, the Jive Platform, offers social business capabilities that enable employee, customer and partner engagement on a unified platform. The core platform can be expanded by adding optional modules, including Jive Present, Gamification, Ideation, Mobile, Video, and connectors into existing enterprise systems and applications. The Company's platform can also be extended to include cloud and customer-built applications through the Jive Apps Market. All of this activity and content is aggregated and presented to users via the Jive What Matters layer.
The Jive Platform serves two types of communities: Employees and Customers and partners. The Company's platform connects users across the enterprise and its functional departments, leveraging social intelligence, such as business relationships and areas of interest, to proactively provide relevant documents, discussions and other content to users. The Company's platform enables the Company's customers to build and manage external communities to build their brand, increase interaction and feedback, and reduce their support costs through enhanced online communication with their own customers and business partners.
The Jive Platform enables rich social profiles, visual enterprise directories, connections and identification. Users can easily find, follow and access both people and data through structured spaces, including public and private social groups and projects. This provides users with up to the minute access to relevant and critical information. The Company's platform enables blogging, microblogging, discussions, real time chat and video conversations and direct messaging and aggregates these familiar methods of social communications into a social inbox to allow users to find relevant information quickly and easily.
The Company's platform includes wikis, document sharing, an easy-to-use rich text editor, and full-fidelity rendering of Micros! oft Offic! e documents and PDFs with inline commenting, allowing users to collaborate real-time. The Company's platform enhances collaboration by allowing users to control access to content at the individual, group or document level. The Company's platform includes advanced search capabilities to locate relevant people, content and groups using information captured in the enterprise social graph, such as users' skills or profile information. The Company's platform can integrate with numerous enterprise systems such as customer relationship management, enterprise resource planning, software configuration management, or product lifecycle management systems, via the Company's application programming interfaces, or APIs.
Advisors' Opinion:- [By Jonathan Morgan]
SAP AG (SAP) added 2.1 percent to 59.89 euros. The world�� largest maker of business-management software has ended discussions to acquire Jive Software Inc. (JIVE), which has a market value of more than $1 billion, people familiar with the matter said.
- [By Roberto Pedone]
Another stock that looks poised to trigger a near-term breakout trade is Jive Software (JIVE), which provides a social business software platform. It provides the Jive Engage platform for its customers for business. This stock has been under selling pressure over the last six months, with shares off by 14%.
If you take a look at the chart for Jive Software, you'll notice that this stock recently gapped down sharply from over $17 a share to under $13.50 a share with heavy downside volume. Following that move, shares of JIVE went on to tag its recent low of $12.74 a share. That move has now pushed shares of JIVE into oversold territory, since its current relative strength index reading is 19.23. Oversold can always get more oversold, but it's also an area from which a stock can experience a powerful bounce higher. Shares of JIVE are now starting to trend back up and move within range of triggering a near-term breakout trade.
Traders should now look for long-biased trades in JIVE if it manages to break out above Friday's intraday high of $13.87 a share and then once it clears its gap down day high of $14.13 a share high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 812,638 shares. If that breakout triggers soon, then JIVE will set up to re-fill some of its previous gap down zone that started just above $17 a share.
Traders can look to buy JIVE off any weakness to anticipate that breakout and simply use a stop that sits right below its recent low of $12.74 a share. One could also buy JIVE off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
The short-sellers love this stock, since the current short interest as a percentage of the float for JIVE is very high at 17.6%. This stock could easily experience a sharp short-covering rally if it gets into that gap
- [By Lee Jackson]
The Lazard trading desk said that active traders may want to look at software stocks that still had unusually high short interest. Those included Concur Technologies (NASDAQ: CNQR), Tangoe Inc. (NASDAQ: TNGO), Jive Software (NASDAQ: JIVE), Marketo Inc. (NASDAQ: MKTO), VeriSign Inc. (NASDAQ: VRSN) and VMware Inc. (NYSE: VMW). Stocks with high short interest can explode to the upside if the company gets back on track and short sellers are forced to cover.
10 Best Tech Stocks To Invest In Right Now: Minerva Neurosciences Inc (NERV)
Minerva Neurosciences, Inc. is a biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system (CNS), diseases. The Company�� product candidates are MIN-101, a compound it is developing for the treatment of patients with schizophrenia, and MIN-117, a compound it is developing for the treatment of patients suffering from depressive disorder (MDD). In addition, the Company�� portfolio includes MIN-202, a compound it is co-developing for the treatment of patients suffering from primary and secondary insomnia, and MIN-301, a compound it is developing for the treatment of patients suffering from Parkinson's disease. Its product candidates include MIN-101, MIN-117, MIN-202 and MIN-301.
MIN-101 is a molecule behaving as an antagonist of 5-HT2A and sigma2 receptors, which the Company is developing for the treatment of patients with schizophrenia. MIN-117 is a molecule behaving mainly as an antagonist on 5-HT1A receptors and as an inhibitor of both serotonin and dopamine reuptake, which it is developing for the treatment of patients with MDD. MDD is a subtype and a severe form of depression, with 6% of MDD patients committing suicide. In addition, an available therapy has several side effects, including cognitive impairment, sexual dysfunction and sleep disorders that lead many patients to discontinue therapy. MIN-301 is a soluble recombinant form of the Neuregulin-1b1 (NRG-1b1), protein, which it is developing for the treatment of patients with Parkinson's disease
MIN-202 is a molecule acting as a selective orexin 2 receptor antagonists, which the Company is co-developing for the treatment of patients with insomnia. Insomnia can be the primary condition for patients or a secondary symptom of another medical or psychiatric condition, such as MDD or schizophrenia. It intends to evaluate MIN-202 as a treatment in primary insomnia, as well as secondary insomnia as an adjunctive t! herapy with an antidepressant for the treatment of mood disorders. Unlike many therapies that activate sleep-promoting neurotransmitters, MIN-202 is specifically targeted towards inhibiting the activity of the neurons that promote wakefulness. The Company is co-developing MIN-202 with Janssen Pharmaceutica N.V.
Advisors' Opinion:- [By Monica Gerson]
Minerva Neurosciences, Inc.(NASDAQ: NERV) shares rose 58.33% to $9.50 in pre-market trading following positive study results.
Frontline Ltd. (NYSE: FRO) shares jumped 14.84% to $2.94 in pre-market trading following positive comments from Karen Finerman on CNBC.
10 Best Tech Stocks To Invest In Right Now: MicroStrategy Incorporated(MSTR)
MicroStrategy Incorporated provides enterprise software platforms for business intelligence (BI), and mobile and social intelligence applications worldwide. The company offers MicroStrategy 9, an integrated BI platform that enables businesses to make business decisions. The MicroStrategy 9 platform?s product components comprise Intelligence Server, a foundation for the BI platform; Report Services, a reporting engine delivering production and operational reports, managed metrics reports, and interactive dashboards; OLAP Services that allows Web and desktop users to manipulate Intelligent Cubes databases; Web, a Web interface providing query, reporting, and analysis; Distribution Services that offers automated report and dashboard distribution; Office, which enables Microsoft Office users to create, run, edit, and format MicroStrategy report; and Desktop that provide users access to data through analytical applications. The MicroStrategy 9 platform?s product components al so include Architect, whose data sources are modeled through an intuitive graphical user interface; SDK to integrate MicroStrategy 9 features and functionality into any application on multiple platforms; Integrity Manager to compare and verify reports? consistency; Command Manager that automates MicroStrategy administrative tasks; Enterprise Manager to provide prebuilt reports and dashboards; Object Manager that allows administrators to manage disparate and distributed environments; MultiSource Option allowing users to report, analyze, and monitor data; Transaction Services that provides write-back capabilities; and Clustering Option, a plug-and-play add-on to Intelligence Server. The company also offers technical support, consulting, education, and cloud-based solutions. It serves retail, communications, financial services, insurance, healthcare, manufacturing, technology, consumer goods, and public services industries. The company was founded in 1989 and is headquartered in Tysons Corner, Virginia.
Advisors' Opinion:- [By Victor Selva]
The second place was occupied by MicroStrategy Incorporated (MSTR), a provider of business intelligence and mobile software with 5.5% of the total portfolio and worth $52.6 million. It reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago, and the stock price outperformed the rise in the S&P 500.
- [By Evan Niu, CFA]
What: Shares of MicroStrategy (NASDAQ: MSTR ) have plunged today by as much as 13% after the company reported first-quarter earnings.
So what: Revenue in the first quarter added up to $130.2 million, a 6% decline from a year ago. That translated into a loss from continuing operations of $5.2 million, or $0.46 per share. Those figures looked poor relative to consensus estimates, which were calling for $152.4 million in sales and $0.35 per share in profit.
- [By Seth Jayson]
MicroStrategy (Nasdaq: MSTR ) is expected to report Q2 earnings around July 29. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict MicroStrategy's revenues will wither -1.9% and EPS will wither -40.0%.
10 Best Tech Stocks To Invest In Right Now: Mastercard Incorporated(MA)
MasterCard Incorporated, together with its subsidiaries, provides transaction processing and related services to customers principally in support of their credit, deposit access, electronic cash and automated teller machine payment card programs, and travelers? cheque programs. Its payment solutions include payment programs, marketing, product development, technology, processing, and consulting and information services. The company provides transaction processing services comprising transaction switching, which include authorization, clearing, and settlement; connectivity services, such as network access, equipment, and the transmission of authorization and settlement messages; and other payment-related services consisting of products used to prevent or detect fraudulent transactions, cardholder services, professional consulting and research services, compliance and penalty, account and transaction enhancement services, holograms, and publication services. MasterCard Incor porated manages and licenses payment card brands, including MasterCard, MasterCard Electronic, Maestro, and Cirrus. The company?s payment programs, which are facilitated through its brands, include consumer credit, debit and prepaid programs, commercial payment solutions, and contactless payment solutions. It serves approximately 22,000 financial institutions. The company was founded in 1966 and is headquartered in Purchase, New York.
Advisors' Opinion:- [By Philip Springer]
Just last week, the major US stock averages hit all-time highs, led by large-cap stocks, including some that had been lagging for many years. But it’s been a different story in March-April for stocks that had the biggest gains of 2013 and early this year.
This week brought more bad news for the stock market’s two most overvalued sectors, biotechnology and information technology. Worse, when the paddy wagon came, as usual it took the good stocks with the bad, to rephrase an old Wall St. aphorism in politically correct terms.
Yesterday, the technology-heavy Nasdaq Composite Index tumbled 3.1 percent, its �biggest one-day drop in nearly 2陆 years. This dragged the broader market sharply lower, as investors resumed selling biotechnology stocks in general and many technology stocks. As of April 10, the Nasdaq Composite was 7 percent off its 14-year high, which was reached last month. Yet the S&P 500 and Dow Jones Industrial Average remain not far from their all-time record peaks, down 3 percent and 2.5 percent respectively.
There are many reasons for the decline of both the junk and the good growth stocks. First, the broad market has been long overdue for a 10 percent correction, which still hasn’t occurred.
Second, the high fliers were much more overdue for a reality check. These particularly include extremely overvalued companies in social media, the “cloud,” 3d printing, biotechnology and more.
Third, the new-issues market, which naturally has consisted primarily of info tech and biotech issues, created too much new supply that inevitably dampened investor demand for the more established companies in those sectors.
The increased importance of trading exchange-traded funds, as both a way to invest and to hedge against market declines, inevitably adds to the downward pressure in this situation.� Reason: Shares of all of their components are sold, regardless of each stock’s relative me - [By Steve Heller]
It seems that once you've grown large enough to disrupt business as usual for MasterCard (NYSE: MA ) and Visa (NYSE: V ) , you run the risk of getting muscled. MasterCard recently announced plans to raise prices on intermediated payment processors (read: digital wallets) that chose to withhold valuable transaction details from MasterCard. In other words, this measure takes direct aim at eBay's (NASDAQ: EBAY ) PayPal and other digital wallets such as Google Wallet that do not share transaction details with the payment processor.
10 Best Tech Stocks To Invest In Right Now: Portola Pharmaceuticals Inc (PTLA)
Portola Pharmaceuticals, Inc. (Portola), incorporated on September 2, 2003, is a biopharmaceutical company developing product candidates that have the potential to represent advances in the fields of thrombosis and hematology. The Company is advancing its three wholly owned programs using biomarker and genetic approaches.
Betrixaban
Portola's compound, betrixaban, is an oral, once-daily Factor Xa inhibitor being evaluated in the only biomarker-based Phase-III study for hospital to home prophylaxis of venous thromboembolism (VTE) in acute medically ill patients. Betrixaban's properties particularly suited to potentially demonstrate efficacy without increasing bleeding in this patient population.
Andexanet Alfa
Portola's second development candidate, andexanet alfa (PRT4445), has the potential to be a reversal agent to directly reverse the effects of Factor Xa inhibitors in patients who suffer a bleeding episode or who require emergency surgery. Portola has entered into clinical collaboration agreements with all of the manufacturers of direct Factor Xa inhibitors, including Bristol-Myers Squibb and Pfizer (Eliquis [apixaban]), Bayer HealthCare and Janssen Pharmaceuticals (XARELTO [rivaroxaban]), and Daiichi Sankyo (Savaysa [edoxaban]), while retaining all decision-making and commercial rights to the program.
Cerdulatinib (PRT2070) and PRT2607
Portola's third wholly owned product candidate, cerdulatinib (PRT2070), is an orally available kinase inhibitor that uniquely inhibits two validated tumor proliferation pathways - spleen tyrosine kinase (Syk) and janus kinase (JAK). It is being studied in patients with leukemias or lymphomas with a focus on genetically-defined subtypes, as well as in patients who have failed therapy due to relapse or acquired mutations. Portola's fourth program is partnered with Biogen Idec and is focused on the development of PRT2607, a selective Syk inhibitor.
Advisors' Opinion:- [By Todd Campbell]
That leads me to Medivation (NASDAQ: MDVN ) , Ophthotech (NASDAQ: OPHT ) , and Portola (NASDAQ: PTLA ) , three companies with important therapies that may very well be destined to become top sellers.
No comments:
Post a Comment